The Changing Face of Fungal Infections in Health Care Settings

Clin Infect Dis. 2005 Nov 15;41(10):1455-60. doi: 10.1086/497138. Epub 2005 Oct 13.

Abstract

As strategies to prevent invasive fungal infections among both hospitalized and nonhospitalized patients have evolved, the epidemiology of these infections has changed. Several unique features of select Candida species and molds have facilitated the emergence of these pathogens as more-common causes of infection than in previous years. In this context, the changing pathogen profiles, unique antifungal susceptibilities, and approaches to treatment are outlined.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / therapeutic use
  • Communicable Diseases, Emerging / epidemiology
  • Communicable Diseases, Emerging / microbiology
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology*
  • Fungemia / drug therapy
  • Fungemia / epidemiology
  • Fungemia / microbiology
  • Humans
  • Incidence
  • Mycoses / drug therapy
  • Mycoses / epidemiology*
  • Mycoses / microbiology
  • Risk Factors

Substances

  • Antifungal Agents